The Environmental Cost of Care
SCIENTIFIC
2000 ; 43 ( 2 ): 405-13 . doi : 10.1002 / 1529- 0131 ( 200002 ) 43:2 < 405 :: AID- ANR22 > 3.0 . CO ; 2-5
4 . Pendergraft WF 3rd , Niles JL . Trojan horses : drug culprits associated with antineutrophil cytoplasmic autoantibody ( ANCA ) vasculitis . Curr Opin Rheumatol . Jan 2014 ; 26 ( 1 ): 42-9 . doi : 10.1097 / BOR . 0000000000000014 doi : 10.1097
5 . Schroeder HA , Morrow JD , Perry HM Jr . Studies on the control of hypertension by hyphex . I . Effects on blood pressure . Circulation . Nov 1953 ; 8 ( 5 ): 672- 80 . doi : 10.1161 / 01 . cir . 8.5.672
6 . Yancy CW , Jessup M , Bozkurt B , et al . 2013 ACCF / AHA guideline for the management of heart failure : a report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines . J Am Coll Cardiol . Oct 15 2013 ; 62 ( 16 ): e147- 239 . doi : 10.1016 / j . jacc . 2013.05.019
7 . Heidenreich PA , Bozkurt B , Aguilar D , et al . 2022 AHA / ACC / HFSA guideline for the management of heart failure : A report of the American College of Cardiology / American Heart Association Joint Committee on Clinical Practice Guidelines . J Am Coll Cardiol . May 03 2022 ; 79 ( 17 ): e263-e421 . doi : 10.1016 / j . jacc . 2021.12.012
8 . Number of people with purchase by prescribed drug , United States , 2009 to 2019 . Medical Expenditure Panel Survey . Agency for Healthcare Research and Quality . Updated July 2021 . Accessed May 5 , 2022 . https :// datatools . ahrq . gov / meps-hc
9 . Medicare part D prescribers – by geography and drug . Centers for Medicare & Medicaid Services . Updated July 2022 . Accessed November 5 , 2022 . https :// data . cms . gov / provider-summaryby-type-of-service / medicare-part-dprescribers / medicare-part-d-prescribersby-geography-and-drug
10 . Morrow JD , Schroeder HA , Perry HM Jr . Studies on the control of hypertension by hyphex . II . Toxic reactions and side effects . Circulation . Dec 1953 ; 8 ( 6 ): 829- 39 . doi : 10.1161 / 01 . cir . 8.6.829
11 . Borchers A , Keen C , Gershwin M . Drug-induced lupus . Ann N Y Acad Sci . Jun 2007 ; 1108:166-82 . doi : 10.1196 / annals . 1422.019
12 . Rubin RL . Drug-induced lupus . Toxicology . Apr 15 2005 ; 209 ( 2 ): 135-47 . doi : 10.1016 / j . tox . 2004.12.025
13 . Yokogawa N , Vivino FB . Hydralazineinduced autoimmune disease : comparison to idiopathic lupus and ANCA-positive vasculitis . Mod Rheumatol . 2009 ; 19 ( 3 ): 338-47 . doi : 10.1007 / s10165-009-0168-y
14 . Bernstein RM , Egerton-Vernon J , Webster J . Hydrallazine-induced cutaneous vasculitis . Br Med J . Jan 19 1980 ; 280 ( 6208 ): 156-7 . doi : 10.1136 / bmj . 280.6208.156-a
15 . Sinclair AJ , Warrington SJ . Severe renal failure in hydralazine-induced lupus . Hum Toxicol . 1981 ; 1 ( 1 ): 65-69 . doi : 10.1177 / 096032718100100107
16 . Renal failure , dyspnea and anemia in a 57 year old woman . Clinicopathologic conference . Am J Med . Nov 1981 ; 71 ( 5 ): 876-886 . doi : 10.1016 / 0002- 9343 ( 81 ) 90385-5
17 . Chang C , Gershwin ME . Drugs and autoimmunity--a contemporary review and mechanistic approach . J Autoimmun . May 2010 ; 34 ( 3 ): J266-J275 . doi : 10.1016 / j . jaut . 2009.11.012
18 . Batchelor JR , Welsh KI , Tinoco RM , et al . Hydralazine-induced systemic lupus erythematosus : influence of HLA-DR and sex on susceptibility . Lancet . May 24 1980 ; 1 ( 8178 ): 1107-9 . doi : 10.1016 / s0140- 6736 ( 80 ) 91554-8
The Environmental Cost of Care
With all the stresses and life-changing decisions placed on our health professionals , a healthy environment and climate for themselves and their patients shouldn ’ t be among them .
Our WebCTRL building automation system ensures regulatory adherence , occupant comfort and most importantly eliminates environmental challenges in health facilities .
www . premierbas . com | 304.578.4799
West Virginia Medical Journal • June 2024 • 19